有氧与抗阻运动对超重或肥胖乳腺癌生存者代谢综合征、肌少性肥胖及循环生物标志物的影响:随机对照试验
该随机对照试验纳入100例久坐、超重或肥胖且种族多样的乳腺癌生存者,比较16周监督下中高强度有氧联合抗阻运动与常规护理的效果。运动组代谢综合征z评分、肌少性肥胖及胰岛素、IGF-1、瘦素、脂联素等生物标志物均显著改善,且3个月随访时代谢指标仍优于基线。结论提示联合运动可有效改善代谢综合征及相关指标,支持将监督性临床运动项目纳入乳腺癌治疗与生存照护计划。
要点
- 16周有氧联合抗阻运动显著改善乳腺癌生存者代谢综合征z评分。
- 运动组肌少性肥胖及胰岛素、IGF-1、瘦素、脂联素等生物标志物显著改善。
- 3个月随访时运动组代谢综合征各指标仍显著优于基线。
核心结论
- 有氧联合抗阻运动可有效减轻种族多样、久坐、超重或肥胖乳腺癌生存者的代谢综合征、肌少性肥胖及相关生物标志物。
- 研究结果提示针对性的运动处方可改善乳腺癌生存者代谢综合征,并支持将监督性临床运动项目纳入治疗与生存照护计划。
研究设计与样本
- 随机对照试验纳入100例久坐、超重或肥胖的乳腺癌生存者,随机分为运动组50例与常规护理组50例。
- 运动组接受16周监督下中高强度有氧联合抗阻运动,每周3次,强度为最大心率的65%至85%。
- 主要结局为代谢综合征z评分,并在基线、干预后4个月及3个月随访时测量肌少性肥胖与血清生物标志物。
主要发现
- 干预后运动组代谢综合征z评分较常规护理组显著改善,组间差异为-4.4(95% CI,-5.9至-2.7;P < .001)。
- 干预后运动组肌少性肥胖指标显著改善:四肢骨骼肌质量指数P = .001,体重指数P = .001。
- 干预后运动组胰岛素(P = .002)、IGF-1(P = .001)、瘦素(P = .001)和脂联素(P = .001)较常规护理组显著改善。
- 3个月随访时,运动组所有代谢综合征变量较基线仍显著改善(P < .01)。
临床怎么用
- 对久坐、超重或肥胖的乳腺癌生存者,可考虑制定包含有氧与抗阻运动的针对性运动处方以改善代谢综合征。
- 支持将监督性临床运动项目纳入乳腺癌治疗与生存照护计划。
局限性
- 3个月随访仅纳入运动组,未与常规护理组比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose Metabolic syndrome is associated with an increased risk of cardiovascular disease, type 2 diabetes, and breast cancer recurrence in survivors of breast cancer. This randomized controlled trial assessed the effects of a 16-week combined aerobic and resistance exercise intervention on metabolic syndrome, sarcopenic obesity, and serum biomarkers among ethnically diverse, sedentary, overweight, or obese survivors of breast cancer. Methods Eligible survivors of breast cancer (N = 100) were randomly assigned to exercise (n = 50) or usual care (n = 50). The exercise group participated in supervised moderate-to-vigorous-65% to 85% of heart rate maximum-aerobic and resistance exercise three times per week for 16 weeks. Metabolic syndrome z-score (primary outcome), sarcopenic obesity, and serum biomarkers were measured at baseline, postintervention (4 months), and 3-month follow-up (exercise only). Results Participants were age 53 ± 10.4 years, 46% were obese, and 74% were ethnic minorities. Adherence to the intervention was 95%, and postintervention assessments were available in 91% of participants. Postintervention metabolic syndrome z-score was significantly improved in exercise versus usual care (between-group difference, -4.4; 95% CI, -5.9 to -2.7; P < .001). Sarcopenic obesity (appendicular skeletal mass index, P = .001; body mass index, P = .001) and circulating biomarkers, including insulin ( P = .002), IGF-1 ( P = .001), leptin ( P = .001), and adiponectin ( P = .001), were significantly improved postintervention compared with usual care. At 3-month follow-up, all metabolic syndrome variables remained significantly improved compared with baseline in the exercise group ( P < .01). Conclusion Combined resistance and aerobic exercise effectively attenuated metabolic syndrome, sarcopenic obesity, and relevant biomarkers in an ethnically diverse sample of sedentary, overweight, or obese survivors of breast cancer. Our findings suggest a targeted exercise prescription for improving metabolic syndrome in survivors of breast cancer and support the incorporation of supervised clinical exercise programs into breast cancer treatment and survivorship care plans.
引用
- Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, et al. Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial. J Clin Oncol. 2018. PMID: 29356607. doi:10.1200/JCO.2017.75.7526
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。